Knockdown of P2-HNF4α in SNU449, a human HCC line that exhibits only P2 expression, resulted in a similarly robust increase in BMAL1, while CCND1 was minimally affected (Fig. 3i, j). This evidence concerns the gene HNF4A and hepatocellular carcinoma.